SANTA CLARA, Calif.--(BUSINESS WIRE)--A group of researchers at Harvard Medical School, Virginia Commonwealth University, Agilent Technologies Inc. (NYSE:A), Codon Devices Inc., and Stanford University has used complex mixtures of oligonucleotides in the form of oligonucleotide library synthesis to overcome a major bottleneck in realizing the potential of the newest generation of DNA sequencers to reduce costs and increase throughput on a grand scale.
